{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:44:02Z","timestamp":1792727042570,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.jhep.2014.10.040","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T19:45:13Z","timestamp":1415043913000},"page":"541-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry"],"prefix":"10.1016","volume":"62","author":[{"given":"Liang-Tzung","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chueh-Yao","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Pang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Chun","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney S.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hong","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Lorne J.","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.10.040_b0005","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature04083","article-title":"Hepatitis C and liver transplantation","volume":"436","author":"Brown","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.10.040_b0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bpg.2009.10.012","article-title":"Adverse effects of drugs in the treatment of viral hepatitis","volume":"24","author":"Negro","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2014.10.040_b0015","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.cld.2008.03.010","article-title":"Hepatitis C and liver transplantation: enhancing outcomes and should patients be retransplanted","volume":"12","author":"Verna","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2014.10.040_b0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2893.2012.01634.x","article-title":"Hepatitis C therapy in non-genotype 1 patients: the near future","volume":"19","author":"Wartelle-Bladou","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.10.040_b0025","first-page":"5","article-title":"Advances in the treatment of hepatitis C virus infection","volume":"20","author":"Thomas","year":"2012","journal-title":"Top Antivir Med"},{"key":"10.1016\/j.jhep.2014.10.040_b0030","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2010.10.014","article-title":"Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies","volume":"54","author":"Zeisel","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.10.040_b0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jhep.2014.10.040_b0040","first-page":"1631","article-title":"Replication of hepatitis C virus","volume":"81","author":"Bartenschlager","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2014.10.040_b0045","series-title":"Bupleurum species: scientific evaluation and clinical applications","author":"Pan","year":"2006"},{"key":"10.1016\/j.jhep.2014.10.040_b0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1139\/O07-010","article-title":"Saikosaponin-d attenuates the development of liver fibrosis by preventing hepatocyte injury","volume":"85","author":"Fan","year":"2007","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.jhep.2014.10.040_b0055","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1055\/s-2003-42797","article-title":"Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species","volume":"69","author":"Chiang","year":"2003","journal-title":"Planta Med"},{"key":"10.1016\/j.jhep.2014.10.040_b0060","first-page":"637","article-title":"Chemopreventive effect of saikosaponin-d on diethylinitrosamine-induced hepatocarcinogenesis: involvement of CCAAT\/enhancer binding protein beta and cyclooxygenase-2","volume":"5","author":"Lu","year":"2012","journal-title":"Mol Med Report"},{"key":"10.1016\/j.jhep.2014.10.040_b0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1126\/science.285.5424.110","article-title":"Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line","volume":"285","author":"Lohmann","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.10.040_b0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jhep.2014.10.040_b0075","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1099\/vir.0.81334-0","article-title":"Development and characterization of a transient-replication assay for the genotype 2a hepatitis C virus subgenomic replicon","volume":"86","author":"Targett-Adams","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2014.10.040_b0080","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/hep.22550","article-title":"Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells","volume":"48","author":"Marukian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.040_b0085","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/JVI.00690-07","article-title":"Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus","volume":"81","author":"Jones","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.10.040_b0090","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1053\/j.gastro.2007.08.005","article-title":"Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a\/2a (S52\/JFH1) viruses","volume":"133","author":"Gottwein","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.10.040_b0095","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.22673","article-title":"Development and characterization of hepatitis C virus genotype 1\u20137 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs","volume":"49","author":"Gottwein","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.040_b0100","doi-asserted-by":"crossref","first-page":"9170","DOI":"10.1128\/JVI.00559-10","article-title":"Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver-specific microRNA 122","volume":"84","author":"Lin","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.10.040_b0105","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1073\/pnas.0800422105","article-title":"Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus","volume":"105","author":"Russell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.040_b0110","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.23445","article-title":"Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations","volume":"51","author":"Krieger","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.040_b0115","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1073\/pnas.0402253101","article-title":"CD81 is an entry coreceptor for hepatitis C virus","volume":"101","author":"Cormier","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.040_b0120","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/hep.24610","article-title":"The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry","volume":"54","author":"Ciesek","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.040_b0125","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/hep.24803","article-title":"(\u2212)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry","volume":"55","author":"Calland","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.040_b0130","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1128\/AAC.00633-11","article-title":"Griffithsin has antiviral activity against hepatitis C virus","volume":"55","author":"Meuleman","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2014.10.040_b0135","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/hep.23587","article-title":"Multiple effects of silymarin on the hepatitis C virus lifecycle","volume":"51","author":"Wagoner","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.10.040_b0140","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1053\/j.gastro.2012.03.036","article-title":"A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes","volume":"143","author":"Haid","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.10.040_b0145","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.bmcl.2010.01.084","article-title":"Tellimagrandin I, HCV invasion inhibitor from Rosae Rugosae Flos","volume":"20","author":"Tamura","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jhep.2014.10.040_b0150","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/gutjnl-2012-304299","article-title":"Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells","volume":"63","author":"Anggakusuma","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2014.10.040_b0155","first-page":"1240","article-title":"Structure and action of saikosaponins isolated from Bupleurum falcatum L. II. Metabolic actions of saikosaponins, especially a plasma cholesterol-lowering action","volume":"25","author":"Yamamoto","year":"1975","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jhep.2014.10.040_b0160","doi-asserted-by":"crossref","first-page":"15978","DOI":"10.1073\/pnas.1108558108","article-title":"Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential","volume":"108","author":"Zasloff","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.10.040_b0165","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/lt.21784","article-title":"The natural history of hepatitis C cirrhosis after liver transplantation","volume":"15","author":"Firpi","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.10.040_b0170","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/lt.20405","article-title":"A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients","volume":"11","author":"Davis","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2014.10.040_b0175","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/lt.20876","article-title":"Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study","volume":"12","author":"Schiano","year":"2006","journal-title":"Liver Transpl"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2015.04.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814008071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814008071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T16:40:21Z","timestamp":1690821621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814008071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0168827814008071"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.10.040","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}